Michal Gilon

1.2k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Michal Gilon is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michal Gilon has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Michal Gilon's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Michal Gilon is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Michal Gilon collaborates with scholars based in Israel, Germany and Palestinian Territory. Michal Gilon's co-authors include Imad Matouk, Eli Raveh, Abraham Hochberg, David Halle, Vladimir Sorin, Avraham Hochberg, Abraham Czerniak, Ayala Hubert, Patricia Ohana and Tatiana Birman and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecular Cancer.

In The Last Decade

Michal Gilon

10 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory

2015 428 citations Eli Raveh, Imad Matouk et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Gilon Israel	9	848	833	109	78	67	10	1.0k
Eli Raveh Israel	8	758 0.9×	766 0.9×	97 0.9×	68 0.9×	81 1.2×	8	952
Zhujiang Zhao China	16	341 0.4×	641 0.8×	63 0.6×	45 0.6×	74 1.1×	26	757
Tatiana Birman Israel	13	440 0.5×	500 0.6×	46 0.4×	66 0.8×	79 1.2×	15	663
Barbara Kinga Barták Hungary	18	522 0.6×	589 0.7×	60 0.6×	54 0.7×	239 3.6×	44	890
Andrej Udelnow Germany	10	429 0.5×	509 0.6×	43 0.4×	163 2.1×	275 4.1×	32	853
Guoqing He China	11	520 0.6×	587 0.7×	28 0.3×	31 0.4×	35 0.5×	13	684
Wolfgang Goering Germany	18	273 0.3×	593 0.7×	37 0.3×	132 1.7×	191 2.9×	26	835
Farhad Akbari Moqadam Netherlands	11	425 0.5×	562 0.7×	32 0.3×	23 0.3×	62 0.9×	12	736
Jéssica Rodrigues Plaça Brazil	14	206 0.2×	323 0.4×	53 0.5×	26 0.3×	50 0.7×	28	495
Fuzhen Qi China	14	771 0.9×	808 1.0×	98 0.9×	105 1.3×	82 1.2×	29	1.0k

Countries citing papers authored by Michal Gilon

Since Specialization

Citations

This map shows the geographic impact of Michal Gilon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Gilon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Gilon more than expected).

Fields of papers citing papers by Michal Gilon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Gilon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Gilon. The network helps show where Michal Gilon may publish in the future.

Co-authorship network of co-authors of Michal Gilon

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Gilon. A scholar is included among the top collaborators of Michal Gilon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Gilon. Michal Gilon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Gielchinsky, Ilan, Michal Gilon, Rasha Abu-lail, et al.. (2017). H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study. Biomarkers. 22(7). 661–666. 11 indexed citations

2.

Lavie, Ofer, David Edelman, Tally Levy, et al.. (2017). A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Archives of Gynecology and Obstetrics. 295(3). 751–761. 44 indexed citations

3.

Matouk, Imad, David Halle, Michal Gilon, & Abraham Hochberg. (2015). The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on biological roles and therapeutic potential in Lung Cancer. Journal of Translational Medicine. 13(1). 113–113. 70 indexed citations

4.

Raveh, Eli, Imad Matouk, Michal Gilon, & Abraham Hochberg. (2015). The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory. Molecular Cancer. 14(1). 184–184. 428 indexed citations breakdown →

5.

Matouk, Imad, David Halle, Eli Raveh, et al.. (2015). The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 7(4). 3748–3765. 107 indexed citations

6.

Matouk, Imad, Eli Raveh, Rasha Abu-lail, et al.. (2014). Oncofetal H19 RNA promotes tumor metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(7). 1414–1426. 203 indexed citations

7.

Matouk, Imad, Eli Raveh, Patricia Ohana, et al.. (2013). The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention. International Journal of Molecular Sciences. 14(2). 4298–4316. 82 indexed citations

8.

Sorin, Vladimir, Patricia Ohana, Tatiana Birman, et al.. (2012). H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer. ISRN Oncology. 2012. 1–7. 28 indexed citations

9.

Hasenpusch, Günther, Manish K. Aneja, Dietrich Reinhardt, et al.. (2011). Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth. PLoS ONE. 6(6). e20760–e20760. 34 indexed citations

10.

Gilon, Michal, Noa Sher, Shulamit Cohen, & Uri Gat. (2007). Transcriptional activation of a subset of hair keratin genes by the NF-κB effector p65/RelA. Differentiation. 76(5). 518–530. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact